Cite

HARVARD Citation

    Palladini, G. et al. (2022). A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis. Leukemia & lymphoma. 63 (1), pp. 205-211. [Online]. 
  
Back to record